White House scraps key plan to lower U.S. drug prices; may target drugmakers
NEW YORK/WASHINGTON (Reuters) – The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers…